Alberto-Culver
ACV · Chemicals & Drugs · NYSE · in our data January 2, 1968 to May 10, 2011 (43.4 years)
Our price history begins on January 2, 1968, and Alberto-Culver was already trading then; how long before that, our data does not say. At its peak, on February 7, 2005, the market valued it at $5.0 billion. It left the market when it was bought or merged, last trading at $37.49, -0.5% from its split-adjusted high. Holders got whatever the deal paid, which is not in our price data.
Share prices are adjusted for splits and other share changes, so the high and the last price compare like for like; the peak market value is as it was on the day. The return covers the trading days in our data only: it does not include what holders received, or lost, after the last trade (a merger payout, a bankruptcy), and it does not reach back before 1968. How these numbers are made · Report a data issue.
Play today's Daily DropAlso gone in 2011: Chemicals & Drugs
- Genzyme peaked at $22.4 billion
- King Pharmaceuticals peaked at $10.5 billion
- Cephalon peaked at $6.4 billion
- Nalco Holding Co peaked at $5.4 billion
- Acelity Holdings Inc -redh peaked at $5.3 billion
- Talecris Biotherapeutcs Hldg peaked at $3.7 billion
